Amplification of 17p11.2∼p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma
- 1 December 2002
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 139 (2) , 91-96
- https://doi.org/10.1016/s0165-4608(02)00627-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cytogenetics and Molecular Biology of OsteosarcomaLaboratory Investigation, 2002
- Genomic organisation of the ∼1.5 Mb Smith-Magenis syndrome critical interval: Transcription map, genomic contig, and candidate gene analysisEuropean Journal of Human Genetics, 2001
- The 1.4-Mb CMT1A Duplication/HNPP Deletion Genomic Region Reveals Unique Genome Architectural Features and Provides Insights into the Recent Evolution of New GenesGenome Research, 2001
- The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors.Journal of Neuropathology and Experimental Neurology, 2000
- Molecular mechanism for duplication 17p11.2— the homologous recombination reciprocal of the Smith-Magenis microdeletionNature Genetics, 2000
- DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcomaInternational Journal of Cancer, 1999
- DNA Copy Number Changes in Development and Progression in Leiomyosarcomas of Soft TissuesThe American Journal of Pathology, 1998
- Recurrent Chromosomal Imbalances Detected in Biopsy Material from Oral Premalignant and Malignant Lesions by Combined Tissue Microdissection, Universal DNA Amplification, and Comparative Genomic HybridizationThe American Journal of Pathology, 1998
- Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomasGenes, Chromosomes and Cancer, 1995
- Amplification of the anonymous marker D17S67 in malignant astrocytomasGenes, Chromosomes and Cancer, 1994